Metabolic Health Explained with Chiropractic Restoration

Learn about chiropractic restoration for metabolic health and how it can lead to significant health enhancements.

Abstract

Metabolic flexibility and cellular viability depend on the continuous availability of nicotinamide adenine dinucleotide (NAD+), a critical coenzyme that participates in thousands of biochemical reactions every second. In this educational post for patients and families seeking a clearer understanding of chronic disease, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, describe how progressive declines in cellular energy production drive the interconnected cascade of metabolic syndrome, cardiometabolic disease, musculoskeletal compromise, cardiomyopathy, and neurodegeneration. Working alongside our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who brings more than four decades of clinical experience as an internist, we examine the physiological basis of NAD+ biology, mitochondrial electron transport, sirtuin (SIRT) activation, and systemic inflammation control. At Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, we combine advanced internal medicine oversight, functional diagnostic workups, and evidence-based integrative chiropractic rehabilitation. By treating upstream root causes—specifically mitochondrial decay, oxidative stress, and structural biomechanical dysfunction—we demonstrate how targeted metabolic repletion and neuromusculoskeletal alignment optimize patient recovery, longevity, and clinical outcomes. This post presents findings from leading researchers using modern, evidence-based methods. It explains how non-surgical integrative chiropractic care fits into comprehensive treatment plans for personal injury, chronic pain, and systemic metabolic conditions.

How Our Multidisciplinary Team Integrates Care at Injury Medical Clinic in El Paso

At Injury Medical Clinic PA in El Paso, Texas, clinical care is deliberately structured as a collaborative partnership between internal medicine and integrative chiropractic and functional medicine practice. Dr. Maria Guadalupe Cardenas, MD, serves as Medical Director and Collaborative Physician. With more than forty years of experience as a board-certified internist, she provides medical direction, diagnostic oversight, hemodynamic and organ-function assessment, cardiovascular and renal risk stratification, and safe management of complex polypharmacy. Her expertise ensures that metabolic, cardiopulmonary, and systemic inflammatory conditions receive rigorous medical evaluation before and during any adjunctive therapies.

I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, contribute dual credentials as a chiropractic physician and family nurse practitioner certified in functional medicine and advanced trauma neurology. This allows integration of functional laboratory diagnostics, targeted metabolic and bioenergetic support (including NAD+ pathways), high-velocity low-amplitude adjustments, non-surgical spinal decompression, and active rehabilitation through the PUSH-as-Rx System. Clinical observations and educational resources from our work are available at https://pushasrx.com/.

This multidisciplinary model is common in integrative and injury-care settings. The MD provides medical direction and safety monitoring while the chiropractor addresses biomechanical and neuromusculoskeletal drivers of pain, autonomic imbalance, and functional limitation. Together, we address both the body’s structural chassis and the biochemical engine inside cells. Patients with personal injury, chronic musculoskeletal pain, metabolic fatigue, or progressive degenerative conditions receive coordinated care that includes medical diagnostics, functional medicine nutrition and cofactor repletion, and non-surgical chiropractic and rehabilitation protocols. The goal is not symptom suppression alone, but restoring cellular energy capacity, reducing inflammatory signaling, improving neural and vascular tone, and restoring movement capacity.

Understanding the Cellular Construction Site: Enzymes, Coenzymes, and the Master Molecule NAD+

Every second, human cells execute thousands of synchronized chemical reactions that govern tissue repair after injury, posture control, cognition, cardiovascular rhythm, and metabolic flexibility. These reactions depend on specialized protein catalysts called enzymes. Enzymes lower the activation energy required for biochemical transformation, allowing life-sustaining processes to occur at physiological temperatures and rates. Without enzymes, most reactions would proceed far too slowly to support human physiology.

An enzyme cannot function without its matching coenzyme. Without the coenzyme, the enzyme remains an inactive apoenzyme—structurally present but unable to bind substrate or catalyze the reaction. Among all coenzymes, NAD+ occupies a uniquely central position. It exists in every living cell and cycles between oxidized (NAD+) and reduced (NADH) forms. In its oxidized form, NAD+ accepts high-energy electrons released during the breakdown of carbohydrates, fats, and proteins. The resulting NADH then delivers those electrons to the mitochondrial electron transport chain, where the energy is captured as adenosine triphosphate (ATP), the universal cellular energy currency.

Beyond classic redox function, NAD+ is an essential substrate for non-redox regulatory enzymes. Sirtuins (SIRT1–SIRT7) are class III histone deacetylases that require NAD+ to remove acetyl groups from proteins, thereby governing epigenetic stability, mitochondrial biogenesis, DNA repair, and inflammatory cytokine suppression. Poly(ADP-ribose) polymerases (PARPs) consume NAD+ to detect and repair single- and double-strand DNA breaks. CD38 and related enzymes use NAD+ for calcium signaling and immune-cell communication. When cellular NAD+ pools decline because of advancing age, chronic psychological stress, systemic inflammation, physical trauma, or toxic exposures, these enzymes lose their substrate. DNA damage accumulates, cellular waste products build up, reactive oxygen species overwhelm antioxidant defenses, and ATP production collapses.

Clinicians use NAD+ repletion because it restores the coenzyme pool and reactivates the enzymatic machinery required for energy production, genomic maintenance, and inflammatory control. Without adequate NAD+, even optimally structured cells cannot sustain repair or metabolic flexibility. This is why upstream bioenergetic support is paired with structural and rehabilitation interventions rather than addressing symptoms in isolation.

Atherosclerosis, Endothelial Dysfunction, and NAD+-Dependent Vascular Remodeling

Cardiovascular disease remains a leading cause of morbidity and mortality. Traditional views emphasized passive cholesterol accumulation, yet modern vascular biology shows atherosclerosis is an active, chronic inflammatory and metabolic process driven by endothelial dysfunction, oxidative stress, and mitochondrial exhaustion within the vessel wall. Endothelial NAD+ depletion uncouples endothelial nitric oxide synthase (eNOS). Instead of producing protective nitric oxide (NO) that promotes vasodilation and inhibits platelet aggregation, uncoupled eNOS generates superoxide. Reduced NO bioavailability increases vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) expression, facilitating monocyte adhesion and subendothelial entry. Mitochondrial reactive oxygen species oxidize low-density lipoprotein, which macrophages ingest to form foam cells and necrotic cores of unstable plaques.

Research on NAD+ precursors has demonstrated plaque-modifying effects in experimental models. Supplementation strategies that raise tissue NAD+ activate SIRT1, which deacetylates and inhibits nuclear factor kappa B (NF-κB), thereby downregulating adhesion molecules and reducing inflammatory cell infiltration. Restored cofactor balance recouples eNOS, increasing NO bioavailability and quenching superoxide. Enhanced autophagy and cholesterol efflux via ATP-binding cassette transporters further limit foam-cell formation and stabilize the vessel wall. These findings, drawn from controlled animal and cellular studies, illustrate that restoring the NAD+ pool addresses upstream drivers of atherogenesis rather than merely altering circulating lipid levels.

Within our integrative model, spinal subluxation complexes and autonomic imbalances compound cardiovascular stress. Upper cervical and upper thoracic segments influence cardiac and vascular autonomic tone. Joint restriction can increase sympathetic outflow, raise peripheral resistance, elevate blood pressure, and accelerate arterial shear stress. Precise chiropractic adjustments normalize sympathetic-parasympathetic balance, reduce systemic vascular resistance, and complement the cellular benefits of NAD+ restoration. Dr. Cardenas monitors hemodynamic stability, vascular status, and inflammatory biomarkers while chiropractic and rehabilitation interventions improve thoracic mobility and autonomic regulation. The combined approach is used because vascular health depends on both endothelial biochemistry and neural control of vessel tone; addressing only one leaves residual drivers of progression.

Myocardial Bioenergetics: Overcoming Dilated Cardiomyopathy and Heart Failure

The human heart beats about 100,000 times daily and requires continuous, high-volume ATP production. Under physiological conditions, roughly 90% of myocardial ATP is generated through mitochondrial oxidative phosphorylation via fatty-acid beta-oxidation and pyruvate metabolism. Disruption of this engine rapidly impairs excitation-contraction coupling, promotes ventricular remodeling, and culminates in heart failure. In failing hearts, myocardial NAD+ pools can decline substantially. The mitochondrial deacetylase SIRT3 loses activity, leaving electron-transport-chain proteins hyperacetylated and functionally impaired. Hyperacetylation also favors opening of the mitochondrial permeability transition pore, triggering cardiomyocyte death. Energy-dependent calcium pumps such as SERCA2a fail when ATP is scarce, producing cytosolic calcium overload, diastolic stiffness, and systolic failure. Pro-fibrotic signaling via transforming growth factor-beta promotes interstitial collagen deposition.

Landmark preclinical work shows that NAD+ precursor supplementation restores myocardial NAD+ levels, reactivates SIRT3, removes inhibitory acetyl groups from metabolic enzymes, and improves calcium cycling and contractile function in dilated cardiomyopathy models. One well-characterized study demonstrated that nicotinamide riboside preserved cardiac function and limited remodeling in a mouse model of dilated cardiomyopathy by stabilizing NAD+ and supporting glycolytic and oxidative pathways (Diguet et al., 2018). These results reframed dilated cardiomyopathy as a condition amenable to metabolic rescue rather than solely neurohormonal blockade.

At our clinic, Dr. Cardenas oversees cardiac markers, renal safety, fluid dynamics, and echocardiographic parameters. Concurrently, thoracic spine mobility and chest-wall biomechanics are addressed because chronic cardiopulmonary patients frequently present with hyperkyphosis, costovertebral restrictions, and restricted ribcage excursion that increase respiratory workload and cardiac strain. Gentle thoracic adjustments and rib mobilization improve compliance, reduce sympathetic overdrive from the cardiac plexus, and enhance lymphatic drainage. Non-surgical rehabilitation through PUSH-as-Rx protocols restores functional capacity once cellular energy and mechanical barriers are improved. Myocardial recovery requires both restored bioenergetics and optimized mechanical and autonomic support; isolated pharmacologic or structural care leaves residual limitations.

Type 2 Diabetes: A Mitochondrial Bioenergetic Deficit Rather than Pure Hyperglycemia

Conventional models often treat type 2 diabetes primarily as elevated blood sugar managed by increasing insulin secretion or enhancing glucose excretion. At the cellular level, hyperglycemia is a downstream symptom of mitochondrial dysfunction and impaired energy metabolism driven by NAD+ depletion and oxidative damage. Nutrient overload floods the electron transport chain with NADH. When the proton gradient is not efficiently coupled to ATP synthesis—commonly due to inactivity or cofactor deficiency—electrons leak from complexes I and III, generating superoxide and hydrogen peroxide. This metabolic shrapnel damages mitochondrial DNA, oxidizes membrane cardiolipin, and activates stress kinases that phosphorylate and inhibit insulin receptor substrate-1 on serine residues. Downstream signaling is blunted, GLUT4 transporters fail to reach the plasma membrane, and glucose remains outside the cell. Pancreatic beta cells, which rely on mitochondrial ATP to trigger insulin secretion, eventually exhaust their bioenergetic capacity.

NAD+ repletion restores the NAD+/NADH acceptor ratio, alleviates electron stalling, activates SIRT1 and SIRT3, and promotes mitochondrial biogenesis via PGC-1α. Reduced reactive oxygen species deactivate stress kinases, restoring normal tyrosine phosphorylation of insulin receptor substrate-1 and GLUT4 translocation. Human evidence includes a randomized trial in which nicotinamide mononucleotide increased muscle insulin sensitivity and insulin signaling in overweight or obese postmenopausal women with prediabetes (Yoshino et al., 2021). Preclinical studies have likewise shown improved glucose homeostasis with NAD+ precursor administration.

Diabetic patients frequently develop secondary musculoskeletal complications: neuropathy and radiculopathy from microvascular ischemia, and connective-tissue glycation that stiffens collagen, producing frozen shoulder, spinal degeneration, and diffuse joint restriction. While Dr. Cardenas manages metabolic therapies, insulin parameters, and safety monitoring, chiropractic care removes mechanical nerve-root compression to optimize neural perfusion, restores proprioception and gait stability through sensorimotor balance training within PUSH-as-Rx, and addresses glycated adhesions with soft-tissue mobilization. These interventions are used because glucose control alone does not reverse biomechanical and neural sequelae; simultaneous structural and metabolic care prevents falls, improves function, and supports sustained activity that further benefits mitochondrial health. Clinical observations at https://pushasrx.com/ emphasize individualized nutrition, mitochondrial cofactors, and progressive rehabilitation as foundations for metabolic recovery.

Neurodegeneration and Alzheimer’s Disease: Reframing Type 3 Diabetes and the Amyloid Hypothesis

The amyloid cascade hypothesis has long framed Alzheimer’s disease. Clinical trials that cleared amyloid plaques have largely failed to reverse cognitive decline, suggesting that amyloid deposition is a downstream response to upstream mitochondrial bioenergetic failure and neuroinflammation. The brain consumes more than 20% of the body’s glucose-derived energy despite representing only 2% of body mass. Neurons depend on mitochondrial ATP to maintain membrane potential, power sodium-potassium pumps, release neurotransmitters, and support axonal transport. When cerebral metabolic flexibility declines—sometimes termed type 3 diabetes or cerebral insulin resistance—mitochondrial electron transport collapses, reactive oxygen species surge, and cellular stress alters amyloid precursor protein processing. Amyloid-beta peptides can bind transition metals and quench lipid peroxidation, partly as a stress response. Bioenergetic failure also hyperactivates kinases such as glycogen synthase kinase-3 beta, producing tau hyperphosphorylation, microtubule destabilization, and neurofibrillary tangles.

NAD+ supplementation activates mitochondrial SIRT3, which deacetylates and restores superoxide dismutase 2, quenches radicals, and prevents permeability transition pore opening, thereby protecting hippocampal neurons. Nuclear SIRT1 upregulates non-amyloidogenic processing and suppresses microglial NF-κB-driven inflammation. Enhanced mitophagy clears damaged mitochondria. A pivotal study showed that mitophagy stimulation, including via NAD+ precursors, reduced insoluble amyloid and tau pathology and reversed cognitive deficits in nematode and mouse models (Fang et al., 2019). Earlier work showed NAD+ supplementation normalized key Alzheimer’s features, reduced DNA damage, and improved synaptic plasticity in models with introduced DNA-repair deficiency.

At Injury Medical Clinic, we pair cellular bioenergetics with physical neurovascular dynamics. The glymphatic system clears amyloid-beta and tau via cerebrospinal fluid flow that depends on unobstructed craniovertebral mechanics and venous drainage. Upper-cervical subluxations can impede cerebrospinal fluid dynamics and internal jugular outflow. Precise upper-cervical corrections help optimize glymphatic clearance during sleep and normalize autonomic tone via vagal afferents, activating the cholinergic anti-inflammatory pathway. These techniques matter because both mitochondrial health and mechanical cerebrospinal-fluid dynamics modulate waste clearance and neuroinflammation; restoring one without the other leaves residual drivers of cognitive decline. Dr. Cardenas provides medical oversight of systemic metabolic and inflammatory markers while functional and chiropractic protocols address the neural and vascular components.

The Triad of Chronic Disease: Systemic Inflammation, Insulin Resistance, and Mitochondrial Dysfunction

Chronic degenerative conditions—osteoarthritis, disc herniation, cardiovascular disease, metabolic syndrome, and autoimmune disorders—share a unified pathological triad rather than existing as isolated ailments. Mitochondrial dysfunction produces insufficient ATP and excessive reactive oxygen species. Insulin resistance impairs glucose uptake, promotes lipotoxicity, and generates advanced glycation end-products that cross-link connective tissue. Systemic inflammation, driven by NF-κB and the NLRP3 inflammasome, continuously releases cytokines that degrade extracellular matrix, cartilage, and vascular and neural tissues. The three processes reinforce one another: energy failure impairs repair and autophagy; insulin resistance and glycation stiffen tissues and fuel inflammation; inflammation further damages mitochondria and insulin signaling.

When energy falls below a critical threshold, DNA-repair enzymes (PARP and SIRT) stall, autophagy and mitophagy decline, damaged organelles and misfolded proteins accumulate, and cells enter senescence. Senescent cells secrete a pro-inflammatory senescence-associated secretory phenotype that damages neighboring tissue and perpetuates pain and degeneration. Clinically, interventions must simultaneously support mitochondrial capacity, improve insulin signaling, and reduce inflammatory tone while addressing structural drivers of pain and restricted movement. Isolated approaches leave residual cycles intact.

Integrative Clinical Practice Protocol at Injury Medical Clinic

Our multi-tiered protocol addresses both structural integrity and cellular metabolism under medical direction.

Tier 1, led by Dr. Maria Guadalupe Cardenas, MD, includes comprehensive metabolic panels, lipid subfractions, high-sensitivity C-reactive protein, hemoglobin A1c, hemodynamic profiling, cardiovascular and renal risk stratification, and rational polypharmacy management. These steps establish safety and identify modifiable medical drivers before adjunctive therapies.

Tier 2 focuses on restoring bioenergetics and metabolism. Subcutaneous or oral NAD+ precursor protocols are titrated to clinical need under oversight. Additional support includes sirtuin and AMPK activators such as resveratrol, quercetin, and berberine; mitochondrial cofactors including coenzyme Q10, alpha-lipoic acid, and B-complex vitamins; and low-glycemic, anti-inflammatory, polyphenol-rich nutrition. These interventions are used because they directly replenish the coenzyme pool, reduce electron leakage, and stimulate biogenesis—actions that pharmacology targeting only downstream glucose or lipid levels cannot fully achieve.

Tier 3, led by the chiropractic and rehabilitation team, includes high-velocity, low-amplitude adjustments to correct subluxation and restore afferent signaling; non-surgical spinal decompression to reduce disc and nerve load; craniocervical alignment to optimize glymphatic and cerebrospinal-fluid dynamics; and PUSH-as-Rx functional rehabilitation for neuromuscular re-education, strength, and injury recovery. Clinical observations shared at https://pushasrx.com/ repeatedly show that patients who combine metabolic support with progressive, pain-free movement achieve better adherence and functional gains because mechanical barriers and inflammatory flares are minimized. Each technique is based on biomechanical and neurological principles: restricted joints alter proprioceptive input and autonomic outflow; decompression reduces mechanical compression that perpetuates inflammation and ischemia; rehabilitation rebuilds capacity once energy and alignment allow safe loading.

The Clinician’s Responsibility: Education, Advocacy, and Patient-Centered Healing

Effective care requires that patients understand why energy is depleted, why tissues hurt, and how spine biomechanics, lifestyle, and cellular biochemistry intersect. When patients grasp these connections, they become active partners rather than passive recipients. This educational commitment underpins practice at Injury Medical Clinic and is reflected in resources at https://pushasrx.com/. Working with Dr. Cardenas, we bring modern evidence on NAD+ biology, mitochondrial restoration, and non-surgical structural care directly to patients across West Texas and Southern New Mexico. By restoring master coenzyme pathways, supporting mitochondrial function, maintaining balanced spinal and neurological alignment, and delivering coordinated medical oversight, patients move beyond symptom management toward restored energy balance, physical resilience, and long-term vitality.

References

• Diguet, N., Trammell, S. A. J., Tannous, C., Deloux, R., Piquereau, J., Mougenot, N., Gouge, A., Gressette, M., Manoury, B., Blanc, J., Breton, M., Decaux, J. F., Lavery, G. G., Baczkó, I., Zoll, J., Garnier, A., Li, Z., Brenner, C., & Mericskay, M. (2018). Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy. Circulation, 137(21), 2256–2273. https://doi.org/10.1161/CIRCULATIONAHA.116.026099
• Fang, E. F., Hou, Y., Palikaras, K., Adriaanse, B. A., Kerr, J. S., Yang, B., Lautrup, S., Hasan-Olive, M. M., Caponio, D., Dan, X., Rocktäschel, P., Croteau, D. L., Akbari, M., Greig, N. H., Fladby, T., Nilsen, H., Cader, M. Z., Mattson, M. P., Tavernarakis, N., & Bohr, V. A. (2019). Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nature Neuroscience, 22(3), 401–412. https://doi.org/10.1038/s41593-018-0332-9
• Yoshino, M., Yoshino, J., Kayser, B. D., Patti, G. J., Franczyk, M. P., Mills, K. F., Sindelar, M., Pietka, T., Patterson, B. W., Imai, S. I., & Klein, S. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229. https://doi.org/10.1126/science.abe9985
• Additional supporting literature includes reviews on NAD+ metabolism in vascular repair and age-related disease, SIRT3 protection in neurodegeneration, and autonomic effects of spinal manipulation documented in chiropractic literature. Clinical observations and rehabilitation protocols are further detailed at https://pushasrx.com/.

SEO Tags

NAD+, nicotinamide adenine dinucleotide, mitochondrial dysfunction, chronic inflammation, type 2 diabetes, Alzheimer’s disease, dilated cardiomyopathy, atherosclerosis, sirtuins, SIRT3, integrative chiropractic, Dr Alex Jimenez, Dr Maria Guadalupe Cardenas, Injury Medical Clinic, functional medicine, spinal alignment, bioenergetics, oxidative stress, ATP production, neurodegeneration, non-surgical treatment, personal injury care, El Paso Texas, PUSH-as-Rx